A carregar...
Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer
OBJECTIVE: To examine survival outcomes of women with recurrent cervical cancer who received salvage chemotherapy with modified dose-dense paclitaxel (MDDP) monotherapy (paclitaxel 80 mg/m(2), administered on day 1, 8, and 15 without day 22). MATERIALS AND METHODS: A retrospective study was conducte...
Na minha lista:
| Publicado no: | Am J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7528455/ https://ncbi.nlm.nih.gov/pubmed/28763329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000394 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|